Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy"

Transcription

1 Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

2 DORA is dedicated to preserving the integrity of the marketplace and is committed to promoting a fair and competitive business environment in Colorado. Consumer protection is our mission.

3 What is the Prescription Drug Monitoring Program (PDMP)? The PDMP is a secure online database of controlled substance prescription data dispensed by pharmacies located in Colorado and other states which are registered by the Colorado State Board of Pharmacy to dispense into Colorado. Colorado s PDMP provides prescribers and pharmacists a secure database with immediate access to their patients history of controlled substance prescriptions. The PDMP helps reduce doctor shopping, the practice by a patient of obtaining controlled substances from multiple health care practitioners and pharmacies without the prescribers or pharmacists knowledge of the other prescriptions. The information in the PDMP can help prescribers and pharmacists make more informed decisions when considering prescribing or dispensing a controlled substance prescription.

4 Why is the PDMP important? More than 255,000 Coloradans misuse prescription drugs. 1 The state health department reports that in 2012, more than twice as many people in Colorado died from overdose due to opioid pain killers than from drunk driving-related crashes (295 compared to 133, respectively). 2 Prescribers are using the PDMP for only 10% of Colorado patients receiving controlled substance prescriptions. Pharmacists are using the PDMP for only 22% of Colorado patients receiving controlled substance prescriptions. Prescribers and pharmacists may be inadvertently enabling the misuse of controlled substances by their Colorado patients when the information available in the PDMP is not used. 1. SAMHSA: NSDUH 2011 Results, 2012; 2. CHPHE: Vital Statistics, 2012;

5 An Enhanced Colorado PDMP: Part of a Comprehensive Solution The prescription drug misuse problem is complex, and requires a comprehensive solution. The Office of National Drug Control Policy and the Centers for Disease Control recommend five interrelated approaches 1 : Increased Public Awareness of the problem Better Education of Physicians and other Health Care Providers, including Dentists, Pharmacists, Nurses, etc. Safe Medication Storage and Disposal Options Increased access to Substance Abuse Treatment Enhanced Prescription Drug Monitoring Programs (PDMPs), to foster better clinical care and protect the public health. 1. ONDCP: Strategic Plan 2012, and CDC: Priorities for Prevention, 2013;

6 An Enhanced Colorado PDMP: Part of a Comprehensive Solution With the support of the Colorado Consortium s PDMP work group, DORA drafted and introduced legislation to enhance the Colorado Prescription Drug Monitoring Program. House Bill describes modifications to Colorado s Electronic Prescription Drug Monitoring Program statute. The program enhancements in the Bill were developed after review of stakeholder recommendations, including those made by Colorado licensed prescribers and pharmacists, and current users of the Colorado PDMP. Changes to Part 4 (CRS ) of the Pharmacists, Pharmacy Businesses and Pharmaceuticals Act resulting from House Bill became effective on May 21, 2014.

7 An Enhanced Colorado PDMP: Part of a Comprehensive Solution House Bill recommendations come after of year of research by more than 200 stakeholders who comprise the Colorado Consortium. The problem of drug misuse in Colorado is significant, and research from other states demonstrates that doctor shopping decreases when prescribers and pharmacists have active PDMP accounts, even when utilization of the PDMP is not mandated. Technical enhancements and legislative changes described in House Bill will make the PDMP easier than ever to use in a busy practice.

8 What does this May 2014 Law do? Mandates PDMP Practitioner / Pharmacist account creation by all Colorado licensed prescribing practitioners with DEA registrations and all Colorado licensed pharmacists. - By SEPTEMBER 30 TH All Colorado licensed Pharmacists & DEA-registered Colorado licensed Advanced Practice Nurses with Prescriptive Authority. - By OCTOBER 31 ST All DEA-registered Colorado licensed Dentists, Veterinarians, Optometrists & Podiatrists. - By NOVEMBER 30 TH All DEA-registered Colorado Medical Board licensees, including Physicians and Physician Assistants.

9 What does this May 2014 Law do? Allows the ability to delegate query of the database to designated PDMP account holders. - Allows Colorado licensed prescribing practitioners and pharmacists with active PDMP accounts the ability to approve designated individuals with their own PDMP accounts the ability to query the PDMP on behalf of the licensed practitioner or pharmacist. - The technical enhancements necessary are scheduled for implementation in January of 2015.

10 What does this May 2014 Law do? Allows the PDMP to send Unsolicited Reports to affected Prescribing Practitioners and Dispensing Pharmacies. - Unsolicited patient history reports of dispensed controlled substance prescriptions to be automatically sent to prescribing practitioners and dispensing pharmacies for the purposes of education and intervention to prevent and reduce occurrences of controlled substance misuse, abuse, and diversion. - No conclusions or judgments are made on the basis of the information provided in an unsolicited patient history report.

11 What does this May 2014 Law do? Allows reporting to the Colorado PDMP by federally owned and operated pharmacies. - Allows controlled substance prescription dispensing data to be reported by federally owned and operated pharmacies registered with the DEA, including pharmacies located in Colorado which are operated by the U.S. Department of Veterans Affairs and pharmacies operated by the U.S. Department of Health and Human Services, Indian Health Services.

12 What does this May 2014 Law do? - Expands Subpoena Authority to law enforcement to now include a pharmacy s PDMP dispensing records. - Provides the Colorado Department of Public Health and Environment access for public health purposes. - Creates a PDMP Taskforce to further study the effectiveness of the PDMP. - Similar to access previously granted to prescribers licensed in another state, now allows access to Colorado PDMP data by pharmacists licensed in other states.

13 What does this May 2014 Law NOT do? Mandate utilization of the PDMP. Mandate delegated access of the PDMP. Mandate any requirements to act on an Unsolicited Report. Provide Law Enforcement direct access to the PDMP.

14 RESOURCES A training guide and demonstration videos for account creation and system utilization are available. Practitioner / Pharmacist tab

15 PDMPs and Interstate Data Sharing

16 MORE INFORMATION Much enhanced PDMP interface coming in 2014 Education outreach Daily uploading by all pharmacies coming in October Questions concerning access, account creation, or system utilization may be addressed to Colorado PDMP staff at , or via to

17 Colorado Prescription Drug Monitoring Program Tia Stakely, MS, PDMP Administrator Colorado Department of Regulatory Agencies Division of Professions and Occupations

New Mexico. Contact Information. Email: Statistics. Technological Capabilities

New Mexico. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - PMP Director 5500 San Antonio Drive NE Albuquerque NM 87109 Office: (505) 222-9837 Fax: (505) 222-9845 Email: @state.nm.us

More information

New Jersey. Contact Information. Statistics. Technological Capabilities

New Jersey. Contact Information. Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Mielo, James - Administrator 124 Halsey St Newark NJ 07102 Office: (973) 273-8010 Fax: Email: NJPMRS mieloj@dca.lps.state.nj.us ASAP

More information

Massachusetts. Contact Information. Statistics. Technological Capabilities

Massachusetts. Contact Information. Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - Assistant Director 99 Chauncy Street Boston MA 02111 Office: (617) 753-8104 Fax: (617) 524-8062 Email: ASAP Versions Accepted

More information

CURES Prescription Drug Monitoring Program

CURES Prescription Drug Monitoring Program California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug

More information

Washington. Contact Information. Email: Statistics. Technological Capabilities

Washington. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington

More information

Georgia. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities

Georgia. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Higgins, Ronnie - Special Agent 40 Pryor St SW, Ste 2000 Atlanta GA 30303 Office: (404) 656-5100 Fax: (404) 651-8210 Email: rhiggins@gdna.ga.gov

More information

Arizona. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities

Arizona. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Arizona State Board of Pharmacy Pharmacy Board Wright, Dean - Program Director P O Box 18520 Phoenix AZ 85005 Office: (602) 771-2744

More information

Colorado. Contact Information. Statistics. Technological Capabilities

Colorado. Contact Information. Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Colorado State Board of Pharmacy Pharmacy Board http://www.hidinc.com/copdmp pdmpinqr@state.co.us Rivera, Janina - PDMP Administrator

More information

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Jackson, Kate - PDMP Manager 55 Wade Ave Catonsville MD 21228 Office: (410) 402-8609 Fax: (410) 402-8601 Email: Maryland Department

More information

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement 2013 Telephone: (781) 609-7741 Fax: (888) 705-8053 Email: info@pdmpassist.org Website: www.pdmpassist.org INTRODUCTION

More information

The Administration s Response to the Prescription Drug Epidemic: Action Items

The Administration s Response to the Prescription Drug Epidemic: Action Items The Administration s Response to the Prescription Drug Epidemic: Action Items As outlined in Epidemic: Responding to America s Prescription Drug Abuse Crisis, below are the action items identified in the

More information

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Delaware Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency Nettesheim, Samantha -

More information

Florida. http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov. Contact Information. Fax: Email: Statistics

Florida. http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov. Contact Information. Fax: Email: Statistics PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Florida Department of Health Department of Health Florida http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov

More information

Prescription Drug Monitoring Program. A Powerful Tool

Prescription Drug Monitoring Program. A Powerful Tool Prescription Drug Monitoring Program A Powerful Tool September 16, 2015 No reportable financial interest. Controlled Substance Utilization Review and Evaluation System >16,000 Prescription Painkiller Overdose

More information

Montana. Contact Information. Email: Statistics. Technological Capabilities

Montana. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Montana Board of Pharmacy Pharmacy Board www.mpdr.mt.gov dlibsdmpdr@mt.gov Peterson, Donna - Program Manager PO Box 200513 Helena MT

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

A New Generation of Prescription Monitoring Programs: Best & Promising Practices

A New Generation of Prescription Monitoring Programs: Best & Promising Practices A New Generation of Prescription Monitoring Programs: Best & Promising Practices National PDMP Meeting Washington, DC September 25, 2013 Presented by John L Eadie Why Is a New Generation of PDMPs Being

More information

Mandatory Prescriber Usage of the Kentucky All Schedule Prescription Electronic Reporting System (KASPER)

Mandatory Prescriber Usage of the Kentucky All Schedule Prescription Electronic Reporting System (KASPER) Mandatory Prescriber Usage of the Kentucky All Schedule Prescription Electronic Reporting System (KASPER) David R. Hopkins KASPER Program Manager Office of Inspector General Kentucky Cabinet for Health

More information

Idaho. Contact Information. Fax: (208) 334-3536 Email: Statistics. Technological Capabilities

Idaho. Contact Information. Fax: (208) 334-3536 Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Idaho Board of Pharmacy Pharmacy Board http://idaho.pmpaware.net pmp@bop.idaho.gov Anderson, Teresa - Program Information Coordinator

More information

South Carolina. South Carolina Department of Health and Environmental Control Department of Health http://www.scdhec.gov/scripts scripts@dhec.sc.

South Carolina. South Carolina Department of Health and Environmental Control Department of Health http://www.scdhec.gov/scripts scripts@dhec.sc. PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Frick, Christie J. - Director (Rph) 2600 Bull St Columbia SC 29201 Office: (803) 896-0688 Fax: (803) 896-0686 Email: SCRIPTS frickcj@dhec.sc.gov

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN)

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN) Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management. The Centers

More information

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations There is currently an epidemic of prescription opioid abuse, misuse and diversion in the U.S. Numerous federal,

More information

Illinois. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities

Illinois. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Berberet, Craig - PMP Manager 401 N Fourth St, Rm 126 Springfield IL 62702 Office: (217) 558-0943 Fax: (217) 557-7975 Email: PIL Department

More information

Alaska Prescription Drug Monitoring Program

Alaska Prescription Drug Monitoring Program Alaska 1. What is a PDMP? PDMP stands for. This is a commonly used term for the programs implemented by various states to monitor the dispensing of controlled substances within their borders. For this

More information

The Public Health and Safety Challenges of Treating Chronic Pain: The Medical Perspective. A Proposed CMS Platform

The Public Health and Safety Challenges of Treating Chronic Pain: The Medical Perspective. A Proposed CMS Platform Recommendations of the Committee on Workers Compensation and Personal Injury and The Special Advisers on Prescription Drug Abuse Approved by the CMS House of Delegates September 21, 2013 The Public Health

More information

Guam. Contact Information. Email: Statistics. Technological Capabilities

Guam. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Naval, Cynthia L. - Planner IV 123 Chalan Kareta Mangilao GU 96913-6304 Office: (671) 735-7204 Fax: (671) 734-5556 Email: GPDMP Guam

More information

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

For a Healthier America: Reducing Prescription Drug Misuse and Abuse For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,

More information

Colorado Consortium for Prescription Drug Abuse Prevention:

Colorado Consortium for Prescription Drug Abuse Prevention: Colorado Consortium for Prescription Drug Abuse Prevention: Quarterly Update to the SATF Robert Valuck, PhD, RPh Coordinating Center Director Helen Kaupang Associate Director Friday, February 7, 2014 #2

More information

Pennsylvania s ABC-MAP Program

Pennsylvania s ABC-MAP Program Pennsylvania s ABC-MAP Program Recommendations on Best Practices ABC-MAP Governance Board Meeting May 20, 2015 Brandon C. Maughan, MD, MHS Marcus A. Bachhuber, MD University of Pennsylvania Philadelphia

More information

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

Prescribers required to check PDMP before first prescription for Controled Substances for new patient. State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,

More information

Harold Rogers Prescription Drug Monitoring Program

Harold Rogers Prescription Drug Monitoring Program Harold Rogers Prescription Drug Monitoring Program 19 th National Conference on Pharmaceutical and Chemical Diversion June 16-17, 2010 Harold Rogers Prescription Drug Monitoring Program Since fiscal year

More information

Program oral testimony

Program oral testimony Office of Policy, Research and Regulatory Reform 2010 Sunset Review: Electronic Prescription Drug Monitoring Program and the Prescription Controlled Substance Abuse Monitoring Committee October 15, 2010

More information

Prescription Drug Monitoring Programs

Prescription Drug Monitoring Programs Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics

More information

2010-2011 Prescription Drug Monitoring Program Annual Report

2010-2011 Prescription Drug Monitoring Program Annual Report 2010-2011 Prescription Drug Monitoring Program Annual Report Prescription Drug Monitoring Program E-FORCSE 4052 Bald Cypress Way, Bin C-16 Tallahassee, FL 32399 (850) 245-4444 X 3700 December 1, 2011 Prescription

More information

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS 2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS Research current through September 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

American Indian Health Commission for Washington State October 1, 2015

American Indian Health Commission for Washington State October 1, 2015 American Indian Health Commission for Washington State October 1, 2015 States with more opioid pain reliever sales tend to have more drug overdose deaths Death rate, 2011, National Vital Statistics System.

More information

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that

More information

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5) HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 103 Medicinal Drug Prescriptions SPONSOR(S): Quinones TIED BILLS: IDEN./SIM. BILLS: SB 132 (i) REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care

More information

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse

More information

NOTE: The governor signed this measure on 5/10/2013.

NOTE: The governor signed this measure on 5/10/2013. NOTE: The governor signed this measure on 5/10/2013. SENATE BILL 13-014 BY SENATOR(S) Aguilar, Guzman, Kefalas, Newell, Steadman, Tochtrop, Todd, Ulibarri; also REPRESENTATIVE(S) Pettersen, Fields, Ginal,

More information

Implementation of Florida s PDMP. Rebecca Poston Program Manager

Implementation of Florida s PDMP. Rebecca Poston Program Manager Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:

More information

COMPILATION OF STATE PRESCRIPTION MONITORING PROGRAM MAPS

COMPILATION OF STATE PRESCRIPTION MONITORING PROGRAM MAPS MTION OF STATE PREPTION NITONG PROGRAM PS This project was supported by Cooperative Agreement No. 202-DC-BX-K002 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component

More information

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations Assisting the Pharmacist Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations, Assisting the Pharmacist PassAssured's Pharmacy Technician Training Program Pharmacy

More information

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices National Governors Association Policy Academy: Reducing Prescription Drug Abuse June 8, 2015 Burlington, VT Improving Interstate

More information

11/26/2012. Implementation of Florida s PDMP. Disclosure

11/26/2012. Implementation of Florida s PDMP. Disclosure Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or

More information

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion

More information

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,

More information

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities

More information

Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program

Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Minnesota Board of

More information

CAPITOL research. Interstate Information Sharing: Prescription Drug Monitoring Programs

CAPITOL research. Interstate Information Sharing: Prescription Drug Monitoring Programs The Council of State governments CAPITOL research APRIL 00 Prescription Drug Monitoring Interstate Information Sharing: Prescription Drug Monitoring Programs The Council of State Governments Misuse of

More information

Maximizing Use of Prescription Drug Monitoring Programs

Maximizing Use of Prescription Drug Monitoring Programs Maximizing Use of Prescription Drug Monitoring Programs Christopher M..Jones, PharmD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease

More information

The Massachusetts Prescription Monitoring Program

The Massachusetts Prescription Monitoring Program The Massachusetts Prescription Monitoring Program A Report to the Massachusetts General Court February 2015 Governor Charles D. Baker Secretary of Health and Human Services Marylou Sudders Massachusetts

More information

SUBSTITUTE FOR HOUSE BILL NO. 5326

SUBSTITUTE FOR HOUSE BILL NO. 5326 SUBSTITUTE FOR HOUSE BILL NO. 5326 A bill to amend 1978 PA 368, entitled "Public health code," by amending sections 7333a, 7422, 17708, and 17757 (MCL 333.7333a, 333.7422, 333.17708, and 333.17757), section

More information

Prescription Drug Misuse in Alberta: Everyone s Problem. A Report by Alberta s Chief Medical Officer of Health September 2011

Prescription Drug Misuse in Alberta: Everyone s Problem. A Report by Alberta s Chief Medical Officer of Health September 2011 Prescription Drug Misuse in Alberta: Everyone s Problem A Report by Alberta s Chief Medical Officer of Health September 2011 Background Story On March 23, 2010, during a symposium on prescription drug

More information

Colorado Plan to Reduce Prescription Drug Abuse

Colorado Plan to Reduce Prescription Drug Abuse Colorado Plan to Reduce Prescription Drug Abuse September 2013 Kelly Perez Policy Advisor Office of Governor John Hickenlooper The Colorado Team (2012/2013) Christine Adams Statistical Analyst/Researcher

More information

RESPONSE TO THE MASSACHUSETTS OPIOID PRESCRIPTION DRUG EPIDEMIC

RESPONSE TO THE MASSACHUSETTS OPIOID PRESCRIPTION DRUG EPIDEMIC RESPONSE TO THE MASSACHUSETTS OPIOID PRESCRIPTION DRUG EPIDEMIC 2014 Report of Best Practices Joint Policy Working Group With the goal of reducing diversion, abuse and addiction and protecting access for

More information

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this

More information

Vermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations

Vermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations Vermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations Vermont Prescription Drug Abuse Workgroup healthvermont.gov dps.vermont.gov Executive Summary In 2008 the Prescription Drug

More information

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS David Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory

More information

CONNECTING FOR IMPACT: Federal Efforts to Integrate Health IT and PDMPs to Improve Patient Care

CONNECTING FOR IMPACT: Federal Efforts to Integrate Health IT and PDMPs to Improve Patient Care CONNECTING FOR IMPACT: Federal Efforts to Integrate Health IT and PDMPs to Improve Patient Care Jinhee Lee, PharmD Substance Abuse and Mental Health Services Administration Jennifer Frazier, MPH Office

More information

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Arizona s Forty-eighth Legislature passed H.B.

More information

AMERICAN PSYCHOLOGICAL ASSOCIATION

AMERICAN PSYCHOLOGICAL ASSOCIATION A. Definitions AMERICAN PSYCHOLOGICAL ASSOCIATION MODEL LEGISLATION FOR PRESCRIPTIVE AUTHORITY Approved by APA Council of Representatives, 2009 (1) Board means the {state psychology licensing board}. (2)

More information

FACT SHEET FOR HEALTH CARE PRACTITIONERS

FACT SHEET FOR HEALTH CARE PRACTITIONERS Florida s Prescription Drug Monitoring Program http://www.e-forcse.com FACT SHEET FOR HEALTH CARE PRACTITIONERS The Florida Prescription Drug Monitoring Program (PDMP), known as E-FORCSE (Electronic- Florida

More information

OREGON DRUG CONTROL UPDATE. Drug Use Trends in Oregon

OREGON DRUG CONTROL UPDATE. Drug Use Trends in Oregon OREGON DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Oregon. Oregon At-a-Glance: In 2009-2010, Oregon was one of the top ten states

More information

Second Annual Florida 2008 Electronic Prescribing Report

Second Annual Florida 2008 Electronic Prescribing Report Second Annual Florida 2008 Electronic Prescribing Report FLORIDA CENTER FOR HEALTH INFORMATION AND POLICY ANALYSIS AGENCY FOR HEALTH CARE ADMINISTRATION JANUARY 2009 Better Health Care for All Floridians

More information

Prescription Drug Abuse

Prescription Drug Abuse DELAWARE DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Delaware. Delaware At-a-Glance: In 2007-2008, Delaware was one of the top

More information

Flagship Priority: Mental Health and Substance Abuse

Flagship Priority: Mental Health and Substance Abuse 10 Colorado s winnable battles Flagship Priority: Mental Health and Substance Abuse ELEVATING HEALTH AND ENVIRONMENT Mental and emotional well-being is essential to shaping a state of health for Coloradans.

More information

Prescription Drug Monitoring Programs: A State Policy to Address Prescription Opioid Poisonings. Michael Kim, MPH April 30, 2012

Prescription Drug Monitoring Programs: A State Policy to Address Prescription Opioid Poisonings. Michael Kim, MPH April 30, 2012 Prescription Drug Monitoring Programs: A State Policy to Address Prescription Opioid Poisonings Michael Kim, MPH April 30, 2012 Overview 1. Prescription Opioid Abuse and Poisoning 2. Prescription Drug

More information

Electronic Prescribing In New York State

Electronic Prescribing In New York State Electronic Prescribing In New York State Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 Overview Review the problem & e-prescribing mandate Describe

More information

PRESCRIPTION PAINKILLER OVERDOSES

PRESCRIPTION PAINKILLER OVERDOSES IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky

More information

Ohio Legislative Service Commission

Ohio Legislative Service Commission Ohio Legislative Service Commission Bill Analysis Lisa Musielewicz S.B. 228 129th General Assembly (As Introduced) Sens. Burke, Lehner, Schiavoni, Tavares, Schaffer BILL SUMMARY Authorizes a certified

More information

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

Our Mission. How does Colorado Medicaid Work? Objectives

Our Mission. How does Colorado Medicaid Work? Objectives How does Colorado Medicaid Work? Understanding the Delivery of Pharmaceutical Care Cathy Traugott, JD, RPh Client and Clinical Care Office Pharmacy Unit Manager Department of Health Care Policy and Financing

More information

Statement of the Federation of State Medical Boards of the United States

Statement of the Federation of State Medical Boards of the United States Statement of the Federation of State Medical Boards of the United States Introduction Drug Enforcement Agency Hearing on Electronic Prescriptions for Controlled Substances Presented by Lisa A. Robin Vice

More information

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program Full source: Wyoming Survey & Analysis Center (2013). Wyoming Prevention Needs Assessment: Interactive Graphing. Laramie, WY: University of Wyoming. (http://pnasurvey.org) Full Source: Wyoming Department

More information

UTAH DRUG CONTROL UPDATE. Substance Abuse Treatment Admissions Data

UTAH DRUG CONTROL UPDATE. Substance Abuse Treatment Admissions Data UTAH DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Utah. Utah At-a-Glance: Approximately 6 percent of Utah residents reported past-month

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS for the Revised: February 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic Online PMP Q: What is

More information

Prescribing in Florida (Guidance Provided by the Florida Department of Health)

Prescribing in Florida (Guidance Provided by the Florida Department of Health) Prescribing in Florida (Guidance Provided by the Florida Department of Health) (Note: This information was contained in a handout for the public at a Florida Board of Medicine meeting held in October 2010.)

More information

Controlled Substance Advisory Committee

Controlled Substance Advisory Committee Date: Tuesday, August 4, 2015, 9:00 AM 12:00 PM Location: Attorney General s Office, 1031 W 4 th Ave, Room 501, Anchorage, AK 99501 Chairperson: Member in Attendance: Robert Henderson (LAW) Leonard (Skip)

More information

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who

More information

Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013

Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013 Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi Signe Shackelford, MPH Policy Analyst November 19, 2013 Center for Mississippi Health Policy Independent, non-profit organization

More information

Enhancing Access to Prescription Drug Monitoring Programs

Enhancing Access to Prescription Drug Monitoring Programs Enhancing Access to Prescription Drug Monitoring Programs Pilot Impact, In Their Own Words Approved for Public Release: 13-1097. Distribution Unlimited. 2013 The MITRE Corporation. All rights reserved.

More information

ANALYSIS AS REPORTED FROM COMMITTEE

ANALYSIS AS REPORTED FROM COMMITTEE PHARMACY TECHNICIAN LICENSURE S.B. 92 (S-5): ANALYSIS AS REPORTED FROM COMMITTEE Senate Bill 92 (Substitute S-5 as reported by the Committee of the Whole) (as passed by the Senate) Sponsor: Senator Mike

More information

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority: Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain

More information

Preliminary Evaluation of the Prescription Drug Monitoring Program

Preliminary Evaluation of the Prescription Drug Monitoring Program Preliminary Evaluation of the Prescription Drug Monitoring Program Recommendations: Waive from full evaluation Extend termination date by three years to July 1, 2019 Require follow-up report by January

More information

SCOPE OF PRACTICE FOR ARNPS

SCOPE OF PRACTICE FOR ARNPS FLORIDA'S PROHIBITION ON ADVANCED REGISTERED NURSE PRACTITIONERS (ARNPs) PRESCRIBING CONTROLLED SUBSTANCES AND THE REQUIREMENTS TO REPORT SUCH ACTIVITY Florida is one of the two states that does not allow

More information

Drug Diversion. Controlled Substance Prescribing and Diversion

Drug Diversion. Controlled Substance Prescribing and Diversion Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation

More information

ARIZONA SUBSTANCE ABUSE PARTNERSHIP Governor s Office for Children, Youth and Families

ARIZONA SUBSTANCE ABUSE PARTNERSHIP Governor s Office for Children, Youth and Families Rx DRUG MISUSE AND ABUSE INITIATIVE IMPLEMENTATION PLAN ARIZONA SUBSTANCE ABUSE PARTNERSHIP Governor s Office for Children, Youth and Families Introduction The Arizona Rx Drug Misuse and Abuse Initiative

More information

State of New York Executive Chamber Andrew M. Cuomo Governor

State of New York Executive Chamber Andrew M. Cuomo Governor State of New York Executive Chamber Andrew M. Cuomo Governor For Immediate Release: August 27, 2012 GOVERNOR CUOMO SIGNS LEGISLATION TO HELP NEW YORK STATE FIGHT PRESCRIPTION DRUG ABUSE Governor Andrew

More information

Prescription Drug Monitoring Programs Bill Status Update

Prescription Drug Monitoring Programs Bill Status Update Prescription Drug Monitoring Programs Bill Status Update Research current through February 24, 2015. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control

More information

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014 Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014 Jeanne Tuttle, R.Ph. National Pharmacist Program Managers Pharmacy Benefits Management Services

More information

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,

More information

What Every Practitioner Needs to Know About Controlled Substance Prescribing

What Every Practitioner Needs to Know About Controlled Substance Prescribing What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of

More information

BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY:

BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY: BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY: About the report About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country s leading innovative

More information

Evaluating Options for the Integration of Electronic Medical Records With the Vermont Prescription Monitoring System

Evaluating Options for the Integration of Electronic Medical Records With the Vermont Prescription Monitoring System Report to The Vermont Legislature Evaluating Options for the Integration of Electronic Medical Records With the In Accordance with Act 75, (2013), Section 13a, An Act Relating to Strengthening Vermont

More information

Division II Medical/Pharmaceutical Services, Education and Oversight Sen. Carson (Thursday) 12/14/2015

Division II Medical/Pharmaceutical Services, Education and Oversight Sen. Carson (Thursday) 12/14/2015 Division II Medical/Pharmaceutical Services, Education and Oversight Carson (Thursday) 12/14/2015 Topic -Division II Expanding Board of Medicine; including practitioner of pain medicine or anesthesiology

More information

ATINER's Conference Paper Series HSC2013-0399

ATINER's Conference Paper Series HSC2013-0399 Athens Institute for Education and Research ATINER ATINER's Conference Paper Series HSC2013-0399 Decreasing Prescription Drug Abuse in the Clinical Setting Rachel Mack, DNP, APRN, C-NP Clinical Instructor

More information

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP

More information

History of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University

History of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University History of Prescription Drug Monitoring Programs PDMP Training and Technical Assistance Center Brandeis University History of Prescription Drug Monitoring Programs First PDMP Early PDMP Characteristics

More information